icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Preclinical characterization of CC-31244, a pan-genotypic, potent NS5B non-nucleoside inhibitor for the treatment of chronic hepatitis C
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Jacobson1, M Feese1, H Xiao1, E Sanchez1, L Uher1, B Lin1, R Tomkiewicz1, T Whitaker2, T McBrayer2, L Pascual2, J Pattassery2, S Lee1 1 Cocrystal Pharma Inc., Bothell, WA 98011 and 2 Cocrystal Pharma Inc., Tucker, GA 30084

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif